Cedars-Sinai Team/Dr Pimentel
- History of Tonsillectomy is Associated with IBS. - letter to the editor
- Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.
- Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome.
- Acute and Chronic Histological Changes of the Small Bowel Secondary to C. jejuni Infection in a Rat Model for Post-Infectious IBS.
- Inflammation and microflora.
- Importance of Diarrhea in Evaluating Constipation in Irritable Bowel Syndrome Clinical Studies.
- Methane on breath testing is associated with constipation: a systematic review and meta-analysis.
- Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome.
- Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS.
- Rifaximin therapy for patients with irritable bowel syndrome without constipation.
- Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome.
Dr Weinstock (& associates)
- Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome.
- Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
- Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth.
- Rosacea in Crohn's Disease: Effect of Rifaximin.
Rome, Italy team
Others
- Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth.
- Gastrointestinal transit in patients with systemic sclerosis.
- Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?
- When to reconsider the diagnosis of irritable bowel syndrome.
- Probable interaction between warfarin and rifaximin in a patient treated for small intestine bacterial overgrowth.
- Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.
- Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors.
- Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
- Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.
- The role of small intestinal bacterial overgrowth in postgastrectomy patients.
- Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.
- Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.
- Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.
In Spanish
In Russian
Learn more |
Vertical Divider
|
